The mitochondrial dynamics of alzheimer's disease and parkinson's disease offer important opportunities for therapeutic intervention

Current Pharmaceutical Design

Volumn 17, Issue 31, 2011, Pages 3374-3380

  Bonda, David J ^a   Smith, Mark A ^a   Perry, George ^b   Lee, Hyoung gon ^a   Wang, Xinglong ^a   Zhu, Xiongwei ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of San Antonio   (United States)

Author keywords

Alzheimer's disease; Dlp 1; Drp 1; Fis1; Fission; Fusion; Mfn1; Mfn2; Mitochondrial dynamics; Neurodegeneration; Parkinson's disease; Therapeutics

Indexed keywords

ALPHA SYNUCLEIN; DYNAMIN I; GUANOSINE TRIPHOSPHATE; LEUCINE RICH REPEAT KINASE 2; MITOCHONDRIAL DNA; MITOFUSIN 1; MITOFUSIN 2; NITRIC OXIDE; PARKIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA;

ALZHEIMER DISEASE; ARTICLE; CALCIUM HOMEOSTASIS; CELL FUSION; CELL PROTECTION; HUMAN; MITOCHONDRION; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ALZHEIMER DISEASE; APOPTOSIS; CALCIUM SIGNALING; CENTRAL NERVOUS SYSTEM AGENTS; HUMANS; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; PARKINSON DISEASE;

EID: 80055078418     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/138161211798072562     Document Type: Article

References (95)

1. Jouaville LS, Pinton P, Bastianutto C, et al. Regulation of mitochondrial ATP synthesis by calcium: evidence for a long-term metabolic priming. Proc Natl Acad Sci USA 1999; 96: 13807-12.
2. Celsi F, Pizzo P, Brini M, et al. Mitochondria, calcium and cell death: a deadly triad in neurodegeneration. Biochim Biophys Acta 2009; 1787: 335-44.
3. Denton RM, McCormack JG. Ca2+ as a second messenger within mitochondria of the heart and other tissues. Annu Rev Physiol 1990; 52: 451-66.
4. Pozzan T, Rizzuto R, Volpe P, Meldolesi J., Molecular and cellular physiology of intracellular calcium stores. Physiol Rev 1994; 74: 595-636.
5. Werth JL, Usachev YM, Thayer SA. Modulation of calcium efflux from cultured rat dorsal root ganglion neurons. J Neurosci 1996; 16: 1008-15.
6. David G, Barrett JN, Barrett EF. Evidence that mitochondria buffer physiological Ca2+ loads in lizard motor nerve terminals. J Physiol 1998; 509 (Pt 1): 59-65.
7. Falcke M, Hudson JL, Camacho P, Lechleiter JD. Impact of mitochondrial Ca2+ cycling on pattern formation and stability. Biophys J 1999; 77: 37-44.
8. Tait SW, Green DR. Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol 2010; 11: 621-32.
9. Chipuk JE, Moldoveanu T, Llambi F, et al. The BCL-2 family reunion. Mol Cell 2010; 37: 299-310.
10. Youle RJ, Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 2008; 9: 47-59.
11. Li K, Li Y, Shelton JM, et al. Cytochrome c deficiency causes embryonic lethality and attenuates stress-induced apoptosis. Cell 2000; 101: 389-99.
12. Haraguchi M, Torii S, Matsuzawa S, et al. Apoptotic protease activating factor 1 (Apaf-1)-independent cell death suppression by Bcl-2. J Exp Med 2000; 191: 1709-20.
13. Kann O, Kovacs R. Mitochondria and neuronal activity. Am J Physiol Cell Physiol 2007; 292: C641-57.
14. Bonda DJ, Wang X, Perry G, et al. Oxidative stress in Alzheimer disease: a possibility for prevention. Neuropharmacology 2010; 59: 290-4.
15. Harman D. Free radical theory of aging: an update: increasing the functional life span. Ann N Y Acad Sci 2006; 1067: 10-21.
16. Harman D. The free radical theory of aging. Antioxid Redox Signal 2003; 5: 557-61.
17. Chan DC. Mitochondria: dynamic organelles in disease, aging, and development. Cell 2006; 125: 1241-52.
18. Chan DC. Mitochondrial fusion and fission in mammals. Annu Rev Cell Dev Biol 2006; 22: 79-99.
19. Chen H, McCaffery JM, Chan DC., Mitochondrial fusion protects against neurodegeneration in the cerebellum. Cell 2007; 130: 62-548.
20. Knott AB, Perkins G, Schwarzenbacher R, Bossy-Wetzel E. Mitochondrial fragmentation in neurodegeneration. Nat Rev Neurosci 2008; 9: 505-18.
21. Su B, Wang X, Zheng L, et al. Abnormal mitochondrial dynamics and neurodegenerative diseases. Biochim Biophys Acta 2010; 1802: 135-42.
22. Chen H, Chomyn A, Chan DC. Disruption of fusion results in mitochondrial heterogeneity and dysfunction. J Biol Chem 2005; 280: 26185-92.
23. Ishihara N, Eura Y, Mihara K. Mitofusin 1 and 2 play distinct roles in mitochondrial fusion reactions via GTPase activity. J Cell Sci 2004; 117: 6535-46.
24. Cipolat S, Martins de Brito O, Dal Zilio B, Scorrano L. OPA1 requires mitofusin 1 to promote mitochondrial fusion. Proc Natl Acad Sci USA 2004; 101: 15927-32.
25. Twig G, Elorza A, Molina AJ, et al. Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. Embo J 2008; 27: 433-46.
26. James DI, Parone PA, Mattenberger Y, Martinou JC. hFis1, a novel component of the mammalian mitochondrial fission machinery. J Biol Chem 2003; 278: 36373-9.
27. Smirnova E, Griparic L, Shurland DL, van der Bliek AM. Dynamin-related protein Drp1 is required for mitochondrial division in mammalian cells. Mol Biol Cell 2001; 12: 2245-56.
28. Youle RJ, Narendra DP. Mechanisms of mitophagy. Nat Rev Mol Cell Biol 2011; 12: 9-14.
29. Chang CR, Blackstone C. Cyclic AMP-dependent protein kinase phosphorylation of Drp1 regulates its GTPase activity and mitochondrial morphology. J Biol Chem 2007; 282: 21583-7.
30. Cribbs JT, Strack S. Reversible phosphorylation of Drp1 by cyclic AMP-dependent protein kinase and calcineurin regulates mitochondrial fission and cell death. EMBO Rep 2007; 8: 939-44.
31. Harder Z, Zunino R, McBride H., Sumo1 conjugates mitochondrial substrates and participates in mitochondrial fission. Curr Biol 2004;14: 5-340.
32. Karbowski M, Neutzner A, Youle RJ. The mitochondrial E3 ubiquitin ligase MARCH5 is required for Drp1 dependent mitochondrial division. J Cell Biol 2007; 178: 71-84.
33. Meuer K, Suppanz IE, Lingor P, et al. Cyclin-dependent kinase 5 is an upstream regulator of mitochondrial fission during neuronal apoptosis. Cell Death Differ 2007; 14: 651-61.
34. Taguchi N, Ishihara N, Jofuku A, et al. Mitotic phosphorylation of dynamin-related GTPase Drp1 participates in mitochondrial fission. J Biol Chem 2007; 282: 11521-9.
35. Chang CR, Blackstone C. Dynamic regulation of mitochondrial fission through modification of the dynamin-related protein Drp1. Ann N Y Acad Sci 2010; 1201: 34-9.
36. Han XJ, Tomizawa K, Fujimura A, et al. Regulation of mitochondrial dynamics and neurodegenerative diseases. Acta Med Okayama 2011; 65: 1-10.
37. Merrill RA, Dagda RK, Dickey AS, et al. Mechanism of Neuroprotective Mitochondrial Remodeling by PKA/AKAP1. PLoS Biol 2011; 9: e1000612.
38. Han XJ, Lu YF, Li SA, et al. CaM kinase I alpha-induced phosphorylation of Drp1 regulates mitochondrial morphology. J Cell Biol 2008; 182: 573-85.
39. Holscher C. Nitric oxide, the enigmatic neuronal messenger: its role in synaptic plasticity. Trends Neurosci 1997; 20: 298-303.
40. Boje KM. Nitric oxide neurotoxicity in neurodegenerative diseases. Front Biosci 2004; 9: 763-76.
41. Dawson VL, Dawson TM. Nitric oxide in neurodegeneration. Prog Brain Res 1998; 118: 215-29.
42. Barsoum MJ, Yuan H, Gerencser AA, et al. Nitric oxide-induced mitochondrial fission is regulated by dynamin-related GTPases in neurons. Embo J 2006; 25: 3900-11.
43. Hom JR, Gewandter JS, Michael L, et al. Thapsigargin induces biphasic fragmentation of mitochondria through calcium-mediated mitochondrial fission and apoptosis. J Cell Physiol 2007; 212: 498-508.
44. Cereghetti GM, Stangherlin A, Martins de Brito O, et al. Dephosphorylation by calcineurin regulates translocation of Drp1 to mitochondria. Proc Natl Acad Sci USA 2008; 105: 15803-8.
45. Liot G, Bossy B, Lubitz S, et al. Complex II inhibition by 3-NP causes mitochondrial fragmentation and neuronal cell death via an NMDA- and ROS-dependent pathway. Cell Death Differ 2009; 16: 899-909.
46. Jendrach M, Mai S, Pohl S, et al. Short- and long-term alterations of mitochondrial morphology, dynamics and mtDNA after transient oxidative stress. Mitochondrion 2008; 8: 293-304.
47. Ichishita R, Tanaka K, Sugiura Y, et al. An RNAi screen for mitochondrial proteins required to maintain the morphology of the organelle in Caenorhabditis elegans. J Biochem 2008; 143: 449-54.
48. Sandebring A, Thomas KJ, Beilina A, et al. Mitochondrial alterations in PINK1 deficient cells are influenced by calcineurin- dependent dephosphorylation of dynamin-related protein 1. PLoS ONE 2009; 4: e5701.
49. Castellani RJ, Rolston RK, Smith MA. Alzheimer disease. Dis Mon 2010; 56: 484-546.
50. Hirai K, Aliev G, Nunomura A, et al. Mitochondrial abnormalities in Alzheimer's disease. J Neurosci 2001; 21: 3017-23.
51. Hyman BT, Van Hoesen GW, Kromer LJ, Damasio AR. Perforant pathway changes and the memory impairment of Alzheimer's disease. Ann Neurol 1986; 20: 472-81.
52. van Strien NM, Cappaert NL, Witter MP. The anatomy of memory: an interactive overview of the parahippocampal-hippocampal network. Nat Rev Neurosci 2009; 10: 272-82.
53. Wang X, Su B, Fujioka H, Zhu X. Dynamin-like protein 1 reduction underlies mitochondrial morphology and distribution abnormalities in fibroblasts from sporadic Alzheimer's disease patients. Am J Pathol 2008; 173: 470-82.
54. Wang X, Su B, Lee HG, et al. Impaired balance of mitochondrial fission and fusion in Alzheimer's disease. J Neurosci 2009; 29: 9090-103.
55. Zhu X, Lee HG, Perry G, Smith MA. Alzheimer disease, the two- hit hypothesis: an update. Biochim Biophys Acta 2007; 1772: 494-502.
56. Schellenberg GD, Bird TD, Wijsman EM, et al. The genetics of Alzheimer's disease. Biomed Pharmacother 1989; 43: 463-8.
57. Hardy J. Alzheimer's disease: the amyloid cascade hypothesis: an update and reappraisal. J Alzheimers Dis 2006; 9: 151-3. Current Pharmaceutical Design, 2011, Vol. 17, No. 31 3379
58. Castellani RJ, Lee HG, Siedlak SL, et al. Reexamining Alzheimer's disease: evidence for a protective role for amyloid-beta protein precursor and amyloid-beta. J Alzheimers Dis 2009; 18: 447-52.
59. Manczak M, Anekonda TS, Henson E, et al. Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum Mol Genet 2006; 15: 1437-49.
60. Rui Y, Tiwari P, Xie Z, Zheng JQ. Acute impairment of mitochondrial trafficking by beta-amyloid peptides in hippocampal neurons. J Neurosci 2006; 26: 10480-7.
61. Wang X, Perry G, Smith MA, Zhu X. Amyloid-beta-derived diffusible ligands cause impaired axonal transport of mitochondria in neurons. Neurodegener Dis 2010; 7: 56-9.
62. Wang X, Su B, Siedlak SL, et al. Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins. Proc Natl Acad Sci USA 2008; 105: 19318-23.
63. Bonda DJ, Wang X, Perry G, et al. Mitochondrial dynamics in Alzheimer's disease: opportunities for future treatment strategies. Drugs Aging 2010; 27: 181-92.
64. Silva DFF, Esteves AR, Oliveira CR, Cardoso SM. Mitochondria: the common upstream driver of amyloid-beta and tau pathology in Alzheimer's disease. Curr Alzheimer Res 2011; 8: 563-572.
65. Santos RX, Correia SC, Wang X, et al. A synergistic dysfunction of mitochondrial fission/fusion dynamics and mitophagy in Alzheimer's disease. J Alzheimers Dis 2010; 20 Suppl 2: S401-12.
66. Lesage S, Brice A. Parkinson's disease: from monogenic forms to genetic susceptibility factors. Hum Mol Genet 2009; 18: R48-59.
67. Abeliovich A, Flint Beal M. Parkinsonism genes: culprits and clues. J Neurochem 2006; 99: 1062-72.
68. Henchcliffe C, Beal MF. Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat Clin Pract Neurol 2008; 4: 600-9.
69. Bender A, Krishnan KJ, Morris CM, et al. High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat Genet 2006; 38: 515-7.
70. Fiskum G, Starkov A, Polster BM, Chinopoulos C. Mitochondrial mechanisms of neural cell death and neuroprotective interventions in Parkinson's disease. Ann N Y Acad Sci 2003; 991: 111-9.
71. Greenamyre JT, Sherer TB, Betarbet R, Panov AV. Complex I and Parkinson's disease. IUBMB Life 2001; 52: 135-41.
72. Gomez-Lazaro M, Bonekamp NA, Galindo MF, et al. 6- Hydroxydopamine (6-OHDA) induces Drp1-dependent mitochondrial fragmentation in SH-SY5Y cells. Free Radic Biol Med 2008; 44: 1960-9.
73. Wang X, Su B, Liu W, et al. DLP1-dependent mitochondrial frag- mentation mediates 1-methyl-4-phenylpyridinium toxicity in neu- rons: implications for Parkinson's disease. Aging Cell 2011; doi: 10.1111/j.1474-9726.2011.00721.x.
74. Clark IE, Dodson MW, Jiang C, et al. Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 2006; 441: 1162-6.
75. Park J, Lee SB, Lee S, et al. Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature 2006; 441: 1157-61.
76. Yang Y, Gehrke S, Imai Y, et al. Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin. Proc Natl Acad Sci USA 2006; 103: 10793-8.
77. Yang Y, Ouyang Y, Yang L, et al. Pink1 regulates mitochondrial dynamics through interaction with the fission/fusion machinery. Proc Natl Acad Sci USA 2008; 105: 7070-5.
78. Mortiboys H, Thomas KJ, Koopman WJ, et al. Mitochondrial function and morphology are impaired in parkin-mutant fibroblasts. Ann Neurol 2008; 64: 555-65.
79. Pogson JH, Ivatt RM, Whitworth AJ. Molecular Mechanisms of PINK1-Related Neurodegeneration. Curr Neurol Neurosci Rep 2011; 11: 283-90.
80. Santos RX, Correia SC, Carvalho C, et al. Mitophagy in Neurodegeneration: An Opportunity for Therapy? Curr Drug Targets 2011.
81. Park J, Lee G, Chung J. The PINK1-Parkin pathway is involved in the regulation of mitochondrial remodeling process. Biochem Biophys Res Commun 2009; 378: 23-518
82. Lutz AK, Exner N, Fett ME, et al. Loss of parkin or PINK1 function increases Drp1-dependent mitochondrial fragmentation. J Biol Chem 2009; 284: 22938-51.
83. Exner N, Treske B, Paquet D, et al. Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin. J Neurosci 2007; 27: 12413-8.
84. Grunewald A, Gegg ME, Taanman JW, et al. Differential effects of PINK1 nonsense and missense mutations on mitochondrial function and morphology. Exp Neurol 2009; 219: 266-73.
85. Colantuoni E, Surplus G, Hackman A, et al. Web-based application to project the burden of Alzheimer's disease. Alzheimers Dement 2010; 6: 425-8.
86. Calabrese VP., Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 2007; 69: 223-4; author reply 224.
87. Cassidy-Stone A, Chipuk JE, Ingerman E, et al. Chemical inhibition of the mitochondrial division dynamin reveals its role in Bax/Bak-dependent mitochondrial outer membrane permeabilization. Dev Cell 2008; 14: 193-204.
88. Brooks C, Wei Q, Cho SG, Dong Z. Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models. J Clin Invest 2009; 119: 1275-85.
89. Qi X, Disatnik MH, Shen N, et al. Aberrant mitochondrial fission in neurons induced by protein kinase C{delta} under oxidative stress conditions in vivo. Mol Biol Cell 2011; 22: 256-65.
90. Wareski P, Vaarmann A, Choubey V, et al. PGC-1{alpha} and PGC-1{beta} regulate mitochondrial density in neurons. J Biol Chem 2009; 284: 21379-85.
91. Kelly DP, Scarpulla RC. Transcriptional regulatory circuits controlling mitochondrial biogenesis and function. Genes Dev 2004; 18: 357-68.
92. Lehman JJ, Barger PM, Kovacs A, et al. Peroxisome proliferator- activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. J Clin Invest 2000; 106: 847-56.
93. Lin J, Wu H, Tarr PT, et al. Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature 2002; 418: 797-801.
94. Cui L, Jeong H, Borovecki F, et al. Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell 2006; 127: 59-69.
95. Waterham HR, Koster J, van Roermund CW, et al. A lethal defect of mitochondrial and peroxisomal fission. N Engl J Med 2007; 356: 1736-41.